698
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

Increased Sympathetic Nervous System Impairs Prognosis in Lung Cancer Patients: A Scoping Review of Clinical Studies

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: LMT63 | Received 21 Jul 2023, Accepted 16 Nov 2023, Published online: 16 Jan 2024

References

  • Gibbons CH . Basics of autonomic nervous system function. Handbook Clin. Neurol. 160, 407–418 (2019).
  • Hutchings C , Phillips JA , Djamgoz MB . Nerve input to tumours: pathophysiological consequences of a dynamic relationship. Biochim. Biophys. Acta Rev. Cancer 1874(2), 188411 (2020).
  • Servick K . War of nerves. Science 365(6458), 1071–1073 (2019).
  • Zahalka AH , Frenette PS . Nerves in cancer. Nat. Rev. Cancer 20(3), 143–157 (2020).
  • Entschladen F , Palm D , Lang K , Drell TL IV , Zaenker KS . Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med. Hypotheses 67(1), 33–35 (2006).
  • Hanahan D . Hallmarks of cancer: new dimensions. Cancer Disc. 12(1), 31–46 (2022).
  • Hanahan D , Weinberg RA . Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011).
  • Kappos EA , Engels PE , Tremp M et al. Denervation leads to volume regression in breast cancer. J. Plasti. Reconstr. Aesthet. Surg. 71(6), 833–839 (2018).
  • Makale MT , Kesari S , Wrasidlo W . The autonomic nervous system and cancer. Biocybern. Biomed. Engin. 37(3), 443–452 (2017).
  • Senga SS , Grose RP . Hallmarks of cancer—the new testament. Open Biol. 11(1), 200358 (2021).
  • Magnon C . Role of the autonomic nervous system in tumorigenesis and metastasis. Mol. Cell. Oncol. 2(2), e975643 (2015).
  • March B , Faulkner S , Jobling P et al. Tumor Innervation and Neurosignalling in Prostate Cancer. Nat. Rev. Urol. 17(2), 119–130 (2020).
  • Hutchings C , Phillips J , Djamgoz MB . Nerve input to tumors: pathophysiological consequences of a dynamic relationship. Biochim. Biophys. Acta Rev. Cancer 1874(2), 188411 (2020).
  • Faulkner S , Jobling P , March B , Jiang CC , Hondermarck H . Tumor neurobiology and the war of nerves in cancer. Cancer Discov. 9(6), 702–710 (2019).
  • Nilsson MB , Sun H , Diao L et al. Stress hormones promote EGFR inhibitor resistance in NSCLC: implications for combinations with β-blockers. Sci. Tansl. Med. 9(415), 1–22 (2017).
  • Yazawa T , Kaira K , Shimizu K et al. Prognostic significance of β2-adrenergic receptor expression in non-small-cell lung cancer. Am. J. Transl. Res. 8(11), 5059 (2016).
  • Torre LA , Siegel RL , Ward EM , Jemal A . Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol. Biomarkers Prev. 25(1), 16–27 (2016).
  • Travis WD . Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small-cell carcinomas. Mod. Pathol. 25(1), S18–S30 (2012).
  • Nilsson MB , Le X , Heymach JV . Beta-adrenergic signaling in lung cancer: a potential role for β-blockers. J. Neuroimmune Pharmacol. 15, 27–36 (2020).
  • Al-Wadei HA , Al-Wadei MH , Schuller HM . Cooperative regulation of non-small-cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention. PLOS ONE 7(1), e29915 (2012).
  • Collisson E , Campbell J , Brooks A et al. Comprehensive molecular profiling of lung adenocarcinoma: the cancer genome atlas research network. Nature 511(7511), 543–550 (2014).
  • Nilsson MB , Le X , Heymach JV . β-Adrenergic signaling in lung cancer: a potential role for β-blockers. J. Neuroimmune Pharmacol. 15(1), 27–36 (2020).
  • Zoucas E , Nilsson C , Alm P , Ihse I . Selective microsurgical sympathetic denervation of the rat pancreas. Eur. Surg. Res. 28(5), 367–373 (1996).
  • Kamiya A , Hayama Y , Kato S et al. Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression. Nat. Neurosci. 22(8), 1289–1305 (2019).
  • Horvathova L , Padova A , Tillinger A , Osacka J , Bizik J , Mravec B . Sympathectomy reduces tumor weight and affects expression of tumor-related genes in melanoma tissue in the mouse. Stress 19(5), 528–534 (2016).
  • Neeman E , Zmora O , Ben-Eliyahu S . A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins. Clin. Cancer Res. 18(18), 4895–4902 (2012).
  • Plummer HK , Dhar MS , Cekanova M , Schuller HM . Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5(1), 1–10 (2005).
  • Higgins JP , Thomas J , Chandler J et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons., NJ, USA, 2 (2019).
  • Tricco AC , Lillie E , Zarin W et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169(7), 467–473 (2018).
  • Peters MD , Godfrey CM , Khalil H , McInerney P , Parker D , Soares CB . Guidance for conducting systematic scoping reviews. JBI Evidence Implement. 13(3), 141–146 (2015).
  • Downs SH , Black N . The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Comm. Health 52(6), 377–384 (1998).
  • Hooper P , Jutai JW , Strong G , Russell-Minda E . Age-related macular degeneration and low-vision rehabilitation: a systematic review. Can. J. Ophthalmol. 43(2), 180–187 (2008).
  • Deeks JJ , Dinnes J , D’Amico R et al. Evaluating non-randomised intervention studies. Health Technol. Assess. 7(27), iii–173 (2003).
  • Aydiner A , Ciftci R , Karabulut S , Kilic L . Does beta-blocker therapy improve the survival of patients with metastatic non-small-cell lung cancer? Asian Pacific J. Cancer Preven. 14(10), 6109–6114 (2013).
  • Cata JP , Villarreal J , Keerty D et al. Perioperative beta-blocker use and survival in lung cancer patients. J. Clin. Anesth. 26(2), 106–117 (2014).
  • Chang C-H , Lee C-H , Ko J-C et al. Effect of β-blocker in treatment-naïve patients with advanced lung adenocarcinoma receiving first-generation EGFR-TKIs. Front. Oncol. 10, 583529 (2020).
  • Chaudhary KR , Yan SX , Heilbroner SP et al. Effects of β-Adrenergic antagonists on chemoradiation therapy for locally advanced non-small-cell lung cancer. J. Clin. Med. 8(5), 575 (2019).
  • Coelho M , Imperatori A , Chiaravalli AM et al. Beta1-and beta2-adrenoceptors expression patterns in human non-small-cell lung cancer: relationship with cancer histology. J. Neuroimm. Pharmacol. 14(4), 697–708 (2019).
  • Holmes S , Griffith EJ , Musto G , Minuk GY . Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study. Cancer Epidemiol. 37(6), 881–885 (2013).
  • Kaira K , Kamiyoshihara M , Kawashima O et al. Prognostic impact of β2 adrenergic receptor expression in surgically resected pulmonary pleomorphic carcinoma. Anticancer Res. 39(1), 395–403 (2019).
  • Lin C-S , Lin W-S , Lin C-L , Kao C-H . Carvedilol use is associated with reduced cancer risk: a nationwide population-based cohort study. Int. J. Cardiol. 184, 9–13 (2015).
  • Mei L , Huang C , Wang A , Zhang X . Association between ADRB2, IL33, and IL2RB gene polymorphisms and lung cancer risk in a Chinese Han population. Internation. Immunopharmacol. 77, 105930 (2019).
  • Musselman RP , Bennett S , Li W et al. Association between perioperative beta blocker use and cancer survival following surgical resection. Eur. J. Surg. Oncol. 44(8), 1164–1169 (2018).
  • Numbere B , Fleming KM , Walker A , Card TR . Adrenergic blockers and the risk for common solid cancers: a case–control study. Eur. J. Cancer Prev. 26(1), 86–93 (2017).
  • Oh MS , Guzner A , Wainwright DA et al. The impact of beta blockers on survival outcomes in patients with non–small-cell lung cancer treated with immune checkpoint inhibitors. Clin. Lung Cancer 22(1), e57–e62 (2021).
  • Sakamoto A , Yagi K , Okamura T , Harada T , Usuda J . Perioperative administration of an intravenous beta-blocker landiolol hydrochloride in patients with lung cancer: a Japanese retrospective exploratory clinical study. Scient. Rep. 9(1), 1–6 (2019).
  • Shah SM , Carey IM , Owen CG , Harris T , Dewilde S , Cook DG . Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br. J. Clin. Pharmacol. 72(1), 157–161 (2011).
  • Shao JX , Wang B , Yao YN , Pan ZJ , Shen Q , Zhou JY . Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma. Thor. Cancer 7(5), 588–598 (2016).
  • Udumyan R , Montgomery S , Fang F et al. β-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non–Small Cell Lung Cancer. Cancer Epidemiol. Biomark. Preven. 29(1), 119–126 (2020).
  • Wang H , Hao B , Chen X et al. Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: a case–control study in a Chinese population. Cancer Lett. 240(2), 297–305 (2006).
  • Wang H , Liao Z , Komaki R et al. Improved survival outcomes with the incidental use of β-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann. Oncol. 24(5), 1312–1319 (2013).
  • Wang H , Liao Z , Zhuang Y et al. Incidental receipt of cardiac medications and survival outcomes among patients with stage III non–small-cell lung cancer after definitive radiotherapy. Clin. Lung Cancer 16(2), 128–136 (2015).
  • Weberpals J , Jansen L , Haefeli WE et al. Pre-and post-diagnostic β-blocker use and lung cancer survival: a population-based cohort study. Scient. Reports 7(1), 1–11 (2017).
  • Yang P , Deng W , Han Y et al. Analysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small-cell lung cancer. Am. J. Cancer Res. 7(4), 946 (2017).
  • Ji L , Xu F , Zhang J et al. ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinoma. Scien. Reports 12(1), 15994 (2022).
  • Cui Y , Wen W , Zheng T et al. Use of antihypertensive medications and survival rates for breast, colorectal, lung, or stomach cancer. Am. J. Epidemiol. 188(8), 1512–1528 (2019).
  • Entschladen F , Palm D , Niggemann B , Zaenker KS . The cancer’s nervous tooth: considering the neuronal crosstalk within tumors. Semin Cancer Biol. 18(3), 171–5 (2008).
  • Schuller HM , Cekanova M . NNK-induced hamster lung adenocarcinomas over-express β2-adrenergic and EGFR signaling pathways. Lung Cancer 49(1), 35–45 (2005).
  • Kondratenko T , Zacharova I , Kuzina N et al. Alterations in human lung adrenergic receptors in cancer. Biochem. Mol. Biol. Int. 29(1), 123–130 (1993).
  • Daly C , McGrath J . Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action. Trends Pharmacol. Sci. 32(4), 219–226 (2011).
  • Zahalka AH , Fram E , Lin W et al. Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population. Urol. Oncol. 38(10), 794.e11–794.e16 (2020).
  • Fjæstad KY , Rømer AMA , Goitea V et al. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene 41(9), 1364–1375 (2022).
  • Zhang J , Deng Y-T , Liu J et al. Norepinephrine induced epithelial–mesenchymal transition in HT-29 and A549 cells in vitro . J. Cancer Res. Clin. Oncol. 142(2), 423–435 (2016).
  • Cole SW , Sood AK . Molecular pathways: beta-adrenergic signaling in cancer. Clinical Cancer Res. 18(5), 1201–1206 (2012).
  • Cserép Z , Losoncz E , Balog P et al. The impact of preoperative anxiety and education level on long-term mortality after cardiac surgery. J. Cardiothor. Surg. 7(1), 1–8 (2012).
  • Shaashua L , Shabat-Simon M , Haldar R et al. Perioperative COX-2 and β-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin. Cancer Res. 23(16), 4651–4661 (2017).
  • Haldar R , Ricon-Becker I , Radin A et al. Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: a randomized controlled trial. Cancer 126(17), 3991–4001 (2020).
  • Yap A , Lopez-Olivo M , Dubowitz J et al. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br. J. Anaesth. 121(1), 45–57 (2018).
  • Hayakawa Y , Sakitani K , Konishi M et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer cell 31(1), 21–34 (2017).
  • Romeo HE , Colombo LL , Esquifino AI , Rosenstein RE , Chuluyan HE , Cardinali DP . Slower growth of tumors in sympathetically denervated murine skin. J. Auton. Nerv. Syst. 32(2), 159–164 (1991).
  • Zhao C-M , Hayakawa Y , Kodama Y et al. Denervation suppresses gastric tumorigenesis. Sci. Translat. Med. 6(250), 250ra115 (2014).
  • Guyatt GH , Oxman AD , Schünemann HJ , Tugwell P , Knottnerus A . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J. Clin. Epidemiol. 64(4), 380–382 (2011).
  • Hardman AE . Physical activity and cancer risk. Proc. Nutr. Soc. 60(1), 107–113 (2001).
  • Khan N , Afaq F , Mukhtar H . Lifestyle as risk factor for cancer: evidence from human studies. Cancer Lett. 293(2), 133–143 (2010).
  • Fu Q , Levine BD . Exercise and the autonomic nervous system. Handbook Clinical Neurol. 117, 147–160 (2013).
  • Negrao CE , Middlekauff HR . Exercise training in heart failure: reduction in angiotensin II, sympathetic nerve activity, and baroreflex control. J. Appl. Physiol. 104(3), 577–8 (2008).
  • Rondon E , Brasileiro-Santos MS , Moreira ED et al. Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure. Am. J. Physiol. Heart Circulat. Physiol. 291(6), H2801–H2806 (2006).
  • Rosenwinkel ET , Bloomfield DM , Arwady MA , Goldsmith RL . Exercise and autonomic function in health and cardiovascular disease. Cardiol. Clin. 19(3), 369–387 (2001).
  • Brum P , Bacurau A , Medeiros A , Ferreira J , Vanzelli A , Negrão C . Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function. Braz. J. Med. Biol. Res. 44, 827–835 (2011).
  • Ruiz-Casado A , Martín-Ruiz A , Pérez LM , Provencio M , Fiuza-Luces C , Lucia A . Exercise and the hallmarks of cancer. Trends Cancer 3(6), 423–441 (2017).
  • Steensberg A , van Hall G , Osada T , Sacchetti M , Saltin B , Pedersen BK . Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529(Pt 1), 237–42 (2000).
  • Pedersen B , Steensberg A , Fischer C et al. Searching for the exercise factor: is IL-6 a candidate? J. Muscle Res. Cell Motility 24, 113–119 (2003).
  • Ouchi N , Oshima Y , Ohashi K et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J. Biol. Chem. 283(47), 32802–32811 (2008).
  • Izumiya Y , Hopkins T , Morris C et al. Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 7(2), 159–172 (2008).
  • Hojman P , Gehl J , Christensen JF , Pedersen BK . Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 27(1), 10–21 (2018).
  • Deminice R . Exercício físico para o tratamento do câncer: evidências científicas eo contexto brasileiro. J. Phys. Educ. 33(1), e3301 (2022).